RPL5 and anaplastic large cell lymphoma: However, the observed set of genomic abnormalities that achieve dysregulation of these pathways appears to be unique in BIA-ALCL with highly recurrent activating STAT3 mutations and recurrent deletions of 1p22 involving RPL5 which have not been identified in sALCL to date.